The study investigated Cytokeratin 19 (CK19), a stem cell marker associated with the progenitor subtype, which has been linked to heightened recurrence and therapy resistance in hepatocellular carcinoma. The gene discussed is KRT19; the disease is hepatocellular carcinoma.